<DOC>
	<DOCNO>NCT01596829</DOCNO>
	<brief_summary>Antibiotic treatment disturbs balance intestinal microbiota predispose antibiotic associate diarrhea . Previous study show risk develop diarrhea course antibiotic may reduce simultaneous consumption probiotic . The aim present study assess effect probiotic formula contain four strain reduce risk antibiotic associate diarrhea .</brief_summary>
	<brief_title>Effect Probiotic Formula Reducing Risk Antibiotic-associated Diarrhoea</brief_title>
	<detailed_description>The aim study assess effect probiotic formula reduce risk antibiotic-associated diarrhea ( AAD ) . The study conduct two-arm , parallel group , placebo-controlled , double-blind , randomized clinical trial , stratify age , gender number day antibiotic . The duration patient participation study 7 week ( 3 week supplementation , 4 week follow-up ) . The overall duration study expect approximately 8 month . Adult male female prescribe antibiotic therapy minimum 3 maximum 14 day include study . The incidence AAD evaluate primary end-point . The stool patient present diarrhea test presence Clostridium difficile negative C. difficile , also presence common pathogens cause diarrhea . The overall microbiota analyze fecal sample take regularly phase study .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>1 . Males female age 1865 year . 2 . Patients initiate antibiotic therapy . 3 . The antibiotic therapy consist one following : broad spectrum penicillin , cephalosporin , doxycycline , clarithromycin , ciprofloxacin isoxazolyl penicillin . 4 . The antibiotic therapy expect 3 14 day duration . 5 . Obtained his/her inform consent verbal write information . 6 . Have high probability compliance completion study . 7 . Patients telephone available . 8 . Body Mass Index 19 30 . 1 . Participation clinical trial investigational product drug within 60 day prior screen . 2 . Likeliness noncompliant protocol , unsuitable study investigator reason . 3 . Pregnant breastfeeding woman ; woman plan become pregnant study month . 4 . Presence active diarrhea ( 3 loose watery stool per 24 hour period ) . 5 . Daily consumption probiotic , ferment milk and/or yogurt probiotic . 6 . Known previous reaction , include anaphylaxis , substance composition study product ( i.e . onmedicinal ingredient : Cellulose , hypromellose , magnesium stearate ( vegetable source ) , ascorbic acid , Colloidal silicon dioxide ) . 7 . Presence active , noncontrolled intestinal disease Crohn 's Disease ulcerative colitis . 8 . Regular use proton pump inhibitor . 9 . Bowel surgery , artificial heart valve , history rheumatic heart disease infective endocarditis . 10 . A previous document C. difficile infection &lt; 3 month prior study initiation . 11 . Immunosuppressive therapy health condition cause immunosuppression ( include haematological malignancy , AIDS ) . 12 . Ongoing recent use antibiotic therapy 3 month prior study product first administration . 13 . Planned administration antibiotic broad spectrum penicillin , cephalosporin , doxycycline , ciprofloxacin isoxazolyl penicillin treatment infection . 14 . History drug alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>antibiotic</keyword>
	<keyword>probiotic</keyword>
	<keyword>antibiotic-associated diarrhoea</keyword>
	<keyword>faecal microbiota</keyword>
</DOC>